|
|
|
|
|
|
|
27.02.26 - 22:21
|
Prothena Announces up to $100 Million Share Repurchase Plan (Business Wire)
|
|
|
DUBLIN--(BUSINESS WIRE)--$PRTA #Prothena--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that its Board of Directors has authorized a Share Repurchase Plan under which the Company may repurchase up to $100.0 million of the Company's outstanding ordinary shares, par value $0.01 per share.
Prothena had cash, cash equivalents and restricted cash of $308.4 million and no debt as of December 31, 2025. Excluding any potential purchases under this Share Repurchase Plan, Prothena expects to end the year with approximately $255 million in cash, cash equivalents, and restricted cash. This financial guidance does not include the potential to earn up to $105 million of aggregate clinical milestone payments from strategic partners in 2026 related to the advancement of both coramitug for ATTR amyloidosis with cardiomyopathy by Novo Nordisk and PRX019 for neurodegenerativ...
|
|
|
|
|
27.02.26 - 17:39
|
TAGESVORSCHAU: Termine am 2. März 2026 (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Montag, den 2. März 2026^TERMINE UNTERNEHMEN08:00 GBR: Smith & Nephew, Jahreszahlen08:00 IRL: Bank of Ireland, Jahreszahlen11:00 DEU: Miele, Jahrespressegespräch mit Geschäftszahlen ......
|
|
|
|
|
|
|
|
|
|
|
|
|
26.02.26 - 17:30
|
Perrigo (PRGO) Q4 Earnings Lag Estimates (Zacks)
|
|
|
Perrigo (PRGO) delivered earnings and revenue surprises of -3.75% and +0.72%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
